Neurorehabilitation Devices Market Scope And Analysis

  • Report Code : TIPRE00006824
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 169
Buy Now

Neurorehabilitation Devices Market Analysis 2021 to 2031

Buy Now


Neurorehabilitation Devices Market Report Scope

Report Attribute Details
Market size in 2023 US$ 2,725.76 Million
Market Size by 2031 US$ 7,086.82 Million
Global CAGR (2023 - 2031) 12.7%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Neurorobotic System
  • Brain Computer Interface
  • Non-invasive Stimulators
  • Wearable Devices
By Application
  • Stroke
  • Traumatic Brain Injury
  • Spinal Cord Injury
  • Parkinson
  • s Disease
  • Cerebral Palsy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Blackrock Microsystems Inc
  • Hocoma AG
  • Medtronic Plc
  • Tyromotion GmbH
  • Ekso Bionics Holdings Inc
  • BIONIK
  • Abbott Laboratories
  • Renishaw Plc
  • EMOTIV
  • BioXtreme Ltd
  • Neurorehabilitation Devices Market News and Recent Developments

    The neurorehabilitation devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the neurorehabilitation devices market are listed below:

    • Ekso Bionics Holdings, Inc. received 510(k) clearance from the US Food and Drug Administration (FDA) to market its EksoNR robotic exoskeleton for use with multiple sclerosis patients. It is the first exoskeleton device to receive FDA clearance for rehabilitation in patients with multiple sclerosis. This indication significantly expands the device's use to a broader group of patients. In addition to its FDA clearances, EksoNR is CE-marked and available in Europe. (Source: Ekso Bionics Holdings, Inc., Press Release, June 2022)
    • DIH, a leading global robotics and virtual reality (VR) technology company for advanced rehabilitation care, announced the shift of the strategic commercial agreement made in 2020 with Gorbel, Inc. into the complete purchase of its Rehabilitation Division. All three SafeGait devices will continue to be manufactured in the United States and are now listed with the FDA under DIH Technology, Inc. (Source: DIH, Press Release, October 2022)

    Neurorehabilitation Devices Market Report Coverage and Deliverables

    The "Neurorehabilitation Devices Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

    • Neurorehabilitation devices market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Neurorehabilitation devices market trends, as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST and SWOT analysis
    • Neurorehabilitation devices market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the neurorehabilitation devices market
    • Detailed company profiles